Delivery Order SPE2DR25D2100-SPE2DR26FA1DA
Award Date 1/12/26
Potential Completion Date 1/13/26
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $21,737.00 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens. The contract operates on a firm fixed-price basis with an ultimate completion date of June 10, 2025, and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,410.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pens. The order, with an ultimate completion date of January 13, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a routine pharmaceutical procurement supporting the...
- The Defense Logistics Agency awarded a $16,165.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 5 mg/0.5 mL pens on December 29, 2025, with completion expected by December 30, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $29,274.42 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contractual relationship with DLA for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens with a ceiling value of $21,468.56. This is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $25,437.46 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens on December 16, 2025. This firm fixed-price delivery order, which will be completed by December 17, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major...
- The Defense Logistics Agency awarded a $19,064.54 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on July 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, valued at $35,744.56, is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,939.78 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,348.82 to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on November 24, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction under the company's broader federal contracting...